Please use this identifier to cite or link to this item:
|Title:||Somatostatin receptors in nasopharyngeal carcinoma|
|Authors:||Loh, K.S. |
|Citation:||Loh, K.S., Waser, B., Tan, L.K.S., Ruan, R.S., Stauffer, E., Reubi, J.C. (2002). Somatostatin receptors in nasopharyngeal carcinoma. Virchows Archiv 441 (5) : 444-448. ScholarBank@NUS Repository. https://doi.org/10.1007/s00428-002-0693-y|
|Abstract:||Somatostatin receptors (SS-Rs) are expressed in neuroendocrine tumour tissues where they can be targetted for diagnosis and therapy. This study investigated the presence of SS-Rs in nasopharyngeal carcinoma (NPC), a common cancer in South-East Asia. Nasopharynx biopsy specimens were obtained from 12 NPC patients and 5 patients without tumours. Somatostatin receptor autoradiography was performed using 125I-labelled [Tyr3]-octreotide and 125I-labelled [Leu8, DTrp22, Tyr25]-somatostatin-28 as radioligands. Of the 12 NPC samples 9 showed moderate to high expression of SS-Rs. These were of the sst2 type, based on the rank order of potency of subtype-selective analogues. The 5 non-neoplastic samples, consisting primarily of granulomatous tissue, did not express measurable amounts of SS-Rs. This study demonstrates for the first time the presence of type 2 SS-R in NPC. These receptors may play a role in the management of NPC, as is the case for other somatostatin-expressing tumours.|
|Source Title:||Virchows Archiv|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Aug 17, 2018
WEB OF SCIENCETM
checked on Jul 11, 2018
checked on May 17, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.